Leadership Team

A novel approach to target inflammatory diseases

Dr. Sven Zimmermann


Senior executive with broad experience in strategic development of advanced clinical stage biotech companies.

• CFO at MetrioPharm (2019-2021)

• CFO at Novimmune (2016-2019

• CFO at Auris Medical (2014-2016)

• CFO at PregLem (2008-2014)

• Analyst at UBS (2001-2008)

Dr. Jean-Jacques Garaud

Cofounder and Executive Vice-President, Scientific and Medical Affairs

Senior executive with broad and deep experience in R&D in the pharmaceutical industry

• Co-founder and CEO of Inotrem from 2014 to April 2021

• Head of Pharma Research and Early Development at Roche (2010 to 2012)

• Head of Development and Chief Medical Officer at Roche (2007 to 2010)

• Non-Executive Director Enyo, Lyon

Martin Koch


Senior executive with international experience in finance and operational functions.

• CFO of Genticel, a listed French biotech (2007 – 2017)

• Sales Director, Oncology Cephalon Pharma France (2006 – 2007)

• Controlling and Finance Director functions at Elan & Zeneus Pharma UK (2001 – 2005)

Dr. Marc Derive

Cofounder, CSO

Senior Executive with solid scientific background and drug innovation records

• Led the discovery and early development of TREM-1 inhibitor drug candidates

• Built Inotrem broad and solid patents portfolio (5 patents)

• Creation of INOTREM

Dr. Margarita Salcedo Magguilli


Senior Executive with broad international experience in early drug development.

• Director of Translational Research at the Oncology R&D Unit, Servier International Research Institute

• Director Translational Medicine, LFB biotechnologies